EP0428572A1 - Production de polypeptides pour usage commercial au moyen d'un tissu d'endosperme transforme genetiquement - Google Patents

Production de polypeptides pour usage commercial au moyen d'un tissu d'endosperme transforme genetiquement

Info

Publication number
EP0428572A1
EP0428572A1 EP89908935A EP89908935A EP0428572A1 EP 0428572 A1 EP0428572 A1 EP 0428572A1 EP 89908935 A EP89908935 A EP 89908935A EP 89908935 A EP89908935 A EP 89908935A EP 0428572 A1 EP0428572 A1 EP 0428572A1
Authority
EP
European Patent Office
Prior art keywords
dna sequence
dna
plant
comprised
endosperm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP89908935A
Other languages
German (de)
English (en)
Inventor
John C. Rogers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington University School of Medicine
Original Assignee
University of Washington
Washington University School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University School of Medicine filed Critical University of Washington
Publication of EP0428572A1 publication Critical patent/EP0428572A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/63—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01031—Beta-glucuronidase (3.2.1.31)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/43—Sweetening agents, e.g. thaumatin, monellin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/823—Reproductive tissue-specific promoters
    • C12N15/8234—Seed-specific, e.g. embryo, endosperm
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2422—Alpha-amylase (3.2.1.1.) from plant source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion

Definitions

  • the present invention relates to obtaining genetically transformed monocotyledonous (monocot) plants that produce seeds comprised of endosperm tissue expressing exogenous, polypeptide-encoding DNA.
  • the present invention also relates to the use of such endosperm tissue to produce exogenous proteins, including biologically active substances like insulin, tissue plasminogen factor, and human growth hormone.
  • the endosperm of a monocotyledonous plant is comprised of the aleurone layer and the starchy endosperm. These endosperm tissues develop from a single triploid cell, which is the product of the fusion of a sperm cell nucleus and two egg cell nuclei, an event that is separate from the fusion that gives rise to embryo tissues.
  • Aleurone cells form a layer that surrounds the starchy endosperm of seeds produced by monocot plants, including the agriculturally important cereals.
  • the plant embryo secretes gibberellic acid (GA) , a hormone that causes the aleurone layer to synthesize and secrete large amounts of a limited number of hydrolytic enzymes.
  • GA gibberellic acid
  • a method for obtaining seed comprised of genetically transformed endosperm tissue comprising the steps of (A) providing a genetic construct comprised of (i) a regulatory element which is expressed at high levels in an endosperm cell; (ii) at least one DNA sequence that encodes a polypeptide, which DNA sequence is under the transcriptional control of the regulatory element; and (iii) a terminal-processing signal positioned downstream of the DNA sequence with regard to direction of transcription, (B) injecting the genetic construct into a floral tiller of a cereal plant prior to anthesis in the plant; and thereafter (C) assaying seeds from the injected plant for the presence of an expression product of the DNA sequence in the endosperm of any of the seeds, thereby to identify a seed comprised of genetically transformed endosperm tissue.
  • step (C) of the process comprises assaying for the expression product by using an antibody that recognizes the product.
  • the DNA sequence of the genetic construct has a guanine and cytosine (G+C) content that is greater than 50%.
  • a process has been provided for producing a polypeptide, comprising the steps of: (A) producing genetically transformed endosperm tissue that expresses a genetic construct as described above; and (B) isolating a polypeptide that is the product of such endosperm-based expression.
  • the aforesaid process comprises isolating exogenous protein from the endosperm of seeds obtained from a substantially uniform population of cereal plants.
  • the process comprises isolating a polypeptide expression product of genetically transformed endosperm tissue from medium in which the tissue is cultured.
  • a differentiated monocotyledonous plant that produces seeds comprised of endosperm tissue, such as aleurone tissue, genetically transformed to express an exogenous DNA sequence which encodes a polypeptide.
  • the plant is one of a substantially uniform population of monocotyledonous plants that produce seed comprised, respectively, of endosperm containing an exogenous protein.
  • the exogenous DNA sequence codes for a polypeptide also encoded by a naturally-occurring gene but that has a guanine and cytosine (G+C) content that is higher than that of the naturally-occurring gene.
  • seed of a monocotyledonous plant e.g., wheat, barley, oats, sorghum, rye, millet, rice, maize, sugar cane and coconut palm, which seed contains endosperm comprised of an exogenous polypeptide.
  • Figure 1 is a schematic diagram illustrating the manufacture of a genetic construct suitable for use in accordance with the present invention.
  • Figure 2 is a representation of a Southern- blot hybridization analysis of DNA from control (untransformed) barley plants and plants transformed in accordance with the present invention.
  • Figure 3 is a representation of a gel- electrophoretic analysis of proteins secreted, respectively, by control barley plants and transformed plants within the present invention.
  • Figure 4A is a representation of a Western blot of stained proteins produced, respectively, by a control barley plant and transformed plants within the present invention; 4B is an autoradiograph of the same Western blot.
  • Figure 5 is a schematic diagram illustrating the manufacture of genetic constructs suitable for use with the GUS probe in the present invention.
  • Figure 5A illustrates the construction of plasmid JR124;
  • Figure 5B illustrates the construction of plasmid JR129;
  • Figure 5C illustrates the construction of plasmid JR133.
  • Figure 6 is a collage of two photographs depicting, respectively, fluorescence in the media (Fig. 6A) and in extracts (Fig. 6B) in a screening plate of barley seed ends obtained from tillers injected with the JR124 construct.
  • Figure 7 is a representative assay of tissue extracts from barley seed ends from tillers injected with the JR133 construct.
  • Figure 8A provides the results from hybridizing Southern blots of DNA from two JR124 construct transformants (124-2D2 and 124-2E4) with a probe derived from the GUS coding sequence.
  • Figure 8B shows the results from different digests of DNA from plants transformed with the JR133 construct hybridized with the GUS coding sequence probe.
  • Figure 8C presents the results of similar analyses utilizing different restriction enzymes for DNA from two of the plants (2G7 and 2G10) .
  • Figure 9 presents the autoradiograph of a Southern blot of control barley DNA (C) and DNA for the F 2 generation progeny of the thaumatin transformants 10D1 and 12H2 hybridized with a thaumatin probe.
  • Figure 10 presents the autoradiograph of a Southern blot, demonstrating instability of constructs containing the GUS sequence in transformed plants.
  • Figure 11 presents a Southern blot autoradiograph that demonstrates that GUS sequences were lost from tissues taken from later growth of the JR124-2D2 plant, but were inherited by some of the progeny germinated from seeds of the first tiller of JR124-2D2.
  • Figure 12 presents the results of a Southern- blot analysis of hybridizing DNA in plants transformed according to the present invention.
  • Figure 12A provides the methylation pattern of the 133-series GUS-positive parent DNA fragments in 2G6 compared with control DNA, as assessed by digestion with different enzymes.
  • Figure 12B provides the results of a similar digestion of GUS- hybridizing DNA in 2G8, 4F1, and 4G1.
  • Figure 13A provides the Southern-blot hybridization results of the undigested major GUS-hybridizing sequences separated from bulk chromosomal DNA of 124-2D2#6 compared with those fragments resulting from digestion with EcoRI or Hindlll.
  • Figure 13B provides the electrophoretic results of the undigested GUS-hybridizing fragments in progeny 2G7#3 and 5A7#8 compared with those fragments resulting from digestion with BamHI or EcoRI.
  • Figure 14 provides the results of methylation in the 2.5 kb HindiII-EcoRI fragment hybridizing to the thaumatin probe in DNA from the F 3 plant, G12-2-8, and the F 2 plant, 12H2-4, using Mbol and Mspl.
  • Figure 15 presents photographs depicting fluorescence in the media (Fig. 15A) and extracts (Fig. 15B) from a screening plate of oat seed ends obtained from tillers injected with the JR133 construct.
  • the synthetic capacities of endosperm tissue are harnessed, for production of an exogenous polypeptide, via the transformation of a cereal or other monocot plant with a genetic construct comprised of a DNA sequence (a "structural sequence") encoding the polypeptide and, upstream therefrom with respect to the direction of transcription, a DNA segment containing at least one regulatory element that effects or regulates expression of the structural sequence in endosperm tissue. Downstream of the structural sequence, the genetic construct also includes a DNA segment that contains a terminal-processing signal for completion of the processing of nascent mRNA.
  • terminal-processing signal denotes a nucleotide sequence that is recognized, during post-transcription process of mRNA in vivo, as indicating where a precursor mRNA molecule should be cleaved to yield a mature mRNA species which will be translated.
  • a segment containing a terminal-processing signal can be obtained by comparing cDNA encoding an endosperm-expressed product, such as that for ⁇ -amylase, protease, protease inhibitor, or ⁇ -glucanase, with the genomic DNA coding for the same product, thereby to identify the 3' terminus of the cDNA.
  • ⁇ regulatory element/structural sequence/terminal- processing signal> fusion product Conventional techniques are available for making a ⁇ regulatory element/structural sequence/terminal- processing signal> fusion product, as described, e.g., by Schell, Science 237: 1176-83 (1987); Ellis et al., EMBO J. 6: 11-16 (1987) and Czernilofsky et al., DNA 5: 101- 13 (1986) .
  • the phrase "regulatory element” denotes a nucleotide sequence that influences transcription of a structural sequence by influencing the movement of an RNA polymerase enzyme along the DNA template undergoing transcription.
  • a preferred regulatory element includes (i) a site of initial recognition, prior to binding, between an RNA polymerase molecule and the DNA chain, (ii) a site for RNA polymerase binding and (iii) a site for initiation of transcription.
  • a regulatory element suitable for the present invention should be especially strong in, or specific to, endosperm cells.
  • a regulatory element can be obtained using cDNA produced from messenger RNA molecules (mRNAs) that are found exclusively in aleurone tissue, or at least are present at some stage of development or activation stage in endosperm tissue in amounts some 50-times or greater than corresponding amounts in either leaf and root tissues.
  • mRNAs messenger RNA molecules
  • Illustrative suitable promoters of this sort are the promoters for the low-pi ⁇ -amylase gene (Amy32b) as described by Rogers and Milliman, J. Biol. Chem.
  • total mRNA can be isolated from endosperm cells, and poly(A) RNA selected and used to produce cDNA by reverse transcription, via known methodology described, for example, by Rogers, J. Biol. Chem. 260: 3731-38 (1985) (hereafter "Rogers (1985)”), the contents of which are hereby incorporated by reference.
  • the step of isolating total mRNA can optionally be preceded by a prolonged stimulation of the aleurone cells with GA, thereby to enhance the content of mRNA species transcribed under the control of a regulatory element that is GA-sensitive and, hence, presumably expressed in aleurone cells.
  • the cDNA thus produced is used to probe genomic DNA from a target monocot, such as a cereal crop (wheat, barley, oat, sorghum, rye, millet and rice) , maize, sugar cane or coconut palm, in order to identify a structural sequence responsible for an abundant endosperm mRNA species represented in the cDNA.
  • a segment of genomic DNA bordering the 5'-end of the structural sequence can then be isolated and incorporated into a genetic construct wherein the segment is fused to a structural sequence encoding a "marker" polypeptide which can be readily detected, e.g., using an antibody which recognizes an epitope presented by the polypeptide.
  • a genomic-DNA segment of this sort that is on the order of 1,500 kilobases (kb) in length can be expected to include at • least a promoter which can be employed as the regulatory element in the present invention.
  • the construct thus produced is used to transform a monocot plant so that detection of the marker can serve as an assay for the presence of a suitable regulatory element in a segment isolated, as described above, from genomic DNA.
  • the same basic approach can also be used to introduce marker-encoding sequences into plants for varietal identification purposes, e.g., in the context of distinguishing malting barleys which have heretofore been differentiated only with difficulty.
  • a non-antibiotic marker as described herein, to screen plant transformants represents a departure from conventional practice, whereby transformants are screened on the basis of resistance to kanamycin or some other antibiotic.
  • the latter approach requires expensive and complex facilities for the growth of large numbers of seedlings on precisely defined media into which the antibiotic is introduced.
  • the high intrinsic resistance of cereals to antibiotics like kanamycin also means that the sensitivity of selection of transformants will be low, and that the false-positive rate will be high.
  • transformants In conjunction with screening of transformants as described above, it is preferred that the transformants also be screened for the presence of methylation at adenine and cytosine bases.
  • Transformants characterized by relatively extensive adenine methylation in the sequence GATC are less likely to maintain transforming DNA that is stably heritable. Accordingly, transformants are preferred in which the inserted DNA has undergone comparatively little methylation of adenines, but show some methylation of cytosine residues.
  • restriction enzymes with different sensitivities to methylation, such as Mbol and Sau3AI, or Mspl and Hpall.
  • a preferred means of transforming a monocot plant entails injecting the construct into floral tillers of the target plant and then screening for transformed seeds produced by the injected tillers.
  • aliquots of an aqueous solution that contains the genetic construct are injected, prior to anthesis but after meiosis, into the hollow space above each developing inflorescence; total injected volume is typically around 300 ⁇ l.
  • a floral tiller is allowed to grow to maturity and to produce seeds by self-fertilization or, in the event of self- incompatibility, by cross-pollination with other injected tillers.
  • transformation frequencies can be achieved that are sufficient to permit the development, via the selection method described herein, of genetically-modified plants which express exogenous DNA in endosperm tissue.
  • seed from a putative transformant can be tested for the expression of foreign DNA by first separating the seed into an embryo-containing portion and a tip portion representing about 20% of the seed distal to the embryo. The latter portion is incubated in a suitable medium, which is thereafter tested, e.g., via an ELISA-type assay, to detect the presence of the polypeptide coded for by an exogenous structural sequence.
  • the embryo-containing portion of the seed can be planted to obtain a differentiated monocot plant which can ultimately produce seeds comprised of endosperm tissue expressing the exogenous structural sequence.
  • the desired exogenous DNA sequence can be manifested in a homozygous condition and be capable of being passed on to subsequent generations.
  • a plurality of such transformed seeds are planted to obtain a stand or population of plants, preferably cereal plants, that is substantially uniform to the extent that most or all of the plants in the stand produce seed containing the desired exogenous protein.
  • the plants can be harvested, and the desired protein extracted from the seed, in the course of an otherwise ordinary agricultural operation.
  • transformed seed of the present invention can be used as the source of endosperm cells for culturing in a suitable medium, whence a desired polypeptide synthesized and excreted by the cultured cells can be extracted.
  • a desired polypeptide synthesized and excreted by the cultured cells can be extracted.
  • the technology for isolating and culturing endosperm tissue has long been available, as evidenced by Yomo and Varner, CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY 111-44 (Academic Press 1971) (aleurone tissue) and 2 HANDBOOK OF PLANT CELL CULTURE Ch. 3 (Macmillan 1984) (starchy endosperm tissue) .
  • the range of structural sequences that can be employed in the present invention encompasses, in addition to synthetic sequences, genes or portions of genes that encode products ordinarily made by plants. Typical of such products is the protein thaumatin, found in arils of the fruit of West African plant Thaumatococcus daniellii, which is the sweetest known substance and, hence, a commercially valuable food additive.
  • structural sequences that code for various bacterial and fungal proteases, themselves useful detergent components are suitable for use according to the present invention.
  • cloned sequences are those coding for hormones like insulin, bovine and human growth hormone, erythropoietin, atrial natriuretic factor, and the various colony stimulating factors (M-CSF, G-CSF, GM-CSF, interleukin-3, etc.); other growth and regulatory factors such as epidermal growth factor, insulin-like growth factor-1 and -2, nerve growth factor, transforming growth factor- ⁇ and - ⁇ and platelet-derived growth factor; the interferon proteins IFN- ⁇ and IFN- ; and proteins that are classified as monokines, such as interleukin-l ⁇ , interleukin-1/? and tissue necrosis factor, or lymphokines, like interleukin- 2 and IFN- 7 .
  • hormones like insulin, bovine and human growth hormone, erythropoietin, atrial natriuretic factor, and the various colony stimulating factors (M-CSF, G-CSF, GM-CSF, interleukin-3,
  • the exogenous, polypeptide- encoding DNA used, according to the present invention, to produce transformed aleurone tissue should be rich in the bases guanine (G) and cytosine (C) , in the sense that the (G+C) content of the DNA is higher than 50%, and preferably in the range of 60% to 65%, as determined from the DNA sequence.
  • the class of structural DNAs satisfying this requirement includes virtually all studied cDNAs and genomic clones representing naturally- occurring genes expressed in aleurone tissue. See Khursheed and Rogers, J. Biol. Chem. 263: 18953-18960 (1988); Whittier et al., Nucleic Acids Res. 15: 2515-2535 (1987) .
  • the polypeptide-encoding DNA segment sequence can be modified, for example, using a computer program like "Codon Preference,” available from the University of Wisconsin Genetics Computer Group [see Devereaux et al., Nucleic Acids Res. 12: 387-395 (1984)], to have increased (G+C) content while still encoding the same polypeptide.
  • the encoding sequence can be synthesized by mutation of the cloned cDNA or genomic DNA [see, e.g., CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, Chapter 8 (Ausebel, et al. , eds.
  • the exogenous DNA employed in transforming aleurone tissue pursuant to the present invention should not methylated at adenosine bases.
  • a cloning system that does not methylate adenine is preferably employed.
  • all enteric bacteria possess the so-called dam restriction/methylation enzyme that methylates adenine at all GATC sites; it is for this reason that all plasmids grown in wild-type IL_ coli strains have every GATC site methylated. Dam " E. coli strains are readily available commercially, for example, from Stratagene, La Jolla, CA (strain GM48) , to use in cloning exogenous DNA for the present invention.
  • the nucleotide sequence encoding prothaumatin protein, minus the signal peptide (i.e., the portion involved in the transport of the protein into the rough endoplasmic reticulum) and first seven a ino acids of the mature protein was fused in frame at the codon for the eighth thaumatin amino acid to a sequence coding for the signal peptide portion and first seven amino acids of the so- called "probable amylase/protease inhibitor” (PAPI) barley protein described by Mundy and Rogers, Planta 169: 51-63 (1986) (hereafter "Mundy & Rogers (1986)").
  • PAPI probable amylase/protease inhibitor
  • Prothaumatin cDNA was obtained for this purpose from a plasmid, pUR528, produced by Edens et al.. Gene 18: 1- 12 (1982) (hereafter "Edens (1982)"), the contents of which are hereby incorporated by reference.
  • Prothaumatin-encoding DNA can be synthesized, using conventional methodology, from the nucleotide sequence disclosed by Edens (1982) .
  • pUR528 can be obtained for research purposes from Unilever Research Laboratories (Vlaardingen, the Netherlands) .
  • Figure 1 depicts the approach used in producing genetic constructs that incorporate the above-mentioned marker sequence (designated "JR073”) bracketed, at the 5 1 end, by a segment of cereal (barley) genomic DNA taken upstream from a known ⁇ -amylase structural sequence and, at the 3' end, by another genomic DNA segment containing a terminal-processing signal for the same ⁇ -amylase sequence.
  • the segment containing the regulatory element was about 1.5 kb in length, while the segment comprising the terminal-processing signal was about 215 bp.
  • JR083 incorporated a segment containing a promoter ("Amy32b promoter") , which segment had been positioned just upstream of a known barley ⁇ -amylase gene described by Rogers and Milliman, J. Biol. Chem. 259: 12234-12240 (1984) .
  • Construct No. JR117 included construct No. JR083 and additional exogenous DNA included for experimental purposes.
  • EXAMPLE 2 OBTAINING GENETICALLY-MODIFIED MONOCOT
  • Seeds produced by injected tillers were harvested and placed individually into wells in a 96-well microtiter dish.
  • the tip of each seed opposite the embryo (about 1/5 the volume of the seed) was cut off and placed in an identical position in a duplicate dish.
  • the remaining 4/5 of the seed was stored at 4 ⁇ C for use, as needed, for germination and growth of a plant.
  • the smaller fragments were sterilized by treatment with 70% ethanol (1 minute) and with 0.2% silver nitrate solution (20 minutes) , respectively, and then allowed to air dry for 30 minutes.
  • thaumatin a mixture of thaumatins I and II, referred to hereafter as "thaumatin,” was purchased from Sigma Chemical Company (Cat. No. T7638) and cross-linked with glutaraldehyde, in accordance with Bollum, Proc. Nat'l Acad. Sci. USA 72: 4119-122 (1975).
  • Thaumatin I and thaumatin II differ at five amino acid positions and have slightly different pi's.
  • rabbit albumin 3 mg were dissolved in 0.4 ml of 0.15 M NaCl/0.05 M Tris-HCl solution (TBS; pH 7.9) . To this were added 40 ⁇ l of a 10 mg/ml solution of thaumatin in distilled water, followed with 100 ⁇ l of 21 mM glutaraldehyde (Sigma Chemical Co.) added dropwise over a total time period of one hour. The tube was allowed to incubate at room temperature overnight, and then the cross-linked proteins were dialyzed against 1 1 of TBS at A ⁇ C for six hours.
  • TBS Tris-HCl solution
  • a volume of the protein solution containing 100 ⁇ g was then emulsified with an equal volume of complete Freund's adjuvant and injected at multiple sites subcutaneously in a New Zealand White rabbit.
  • the rabbit was boosted with antigen in incomplete Freund's adjuvant at two week intervals until an adequate antibody titer was obtained.
  • the antiserum obtained was used without further purification in screening for transformed seeds. Later, to minimize nonspecific background in Western blot analyses of proteins produced by transformed plants, antithaumatin antibodies were affinity-purified.
  • This purification was carried out on a thaumatin- sepharose affinity column carrying 5 mg thaumatin/ml cyanogen bromide-activated Sepharose 4B (Sigma Chemical Co.), and coupling of protein was effected according to the manufacturer's direction. Rabbit serum was heat-inactivated at 56 ⁇ C for fifteen minutes, cooled on ice, and then passed through the column at room temperature. The column was washed with TBS until the A 280 of the effluent dropped to background. Specifically, adsorbed immunoglobulins were eluted with 0.2 M glycine/HCl (pH 2.2), dialyzed against TBS, and then stored in aliquots at -20"C.
  • Seed remnants were planted that corresponded to the foregoing test dots that appeared to be above background levels. When the plants grown from these remnants were large enough to tolerate removal of about 0.5-1 g of leaf tissue, that portion was removed and genomic DNA was isolated, pursuant to the methodology of Dellaporta et al. in MOLECULAR BIOLOGY OF PLANTS: A LABORATORY COURSE MANUAL 36-37 (Cold Spring Harbor Laboratory, 1984) . The isolated DNA was then digested with restriction enzymes, electrophoresed, and transferred to Zetaprobe ® nylon membrane (Biorad) for Southern-blot analysis, pursuant to Whittier et al.. Nucleic Acids Res.
  • FIG. 2 A pair of representative Southern blots is presented in Figure 2; these are from gels run in parallel.
  • the DNAs were digested with Hindlll and EcoRI, restriction enzymes that cut the intact construct such that the promoter-gene-terminator sequences (about 2.4 kb) are freed from surrounding DNA.
  • Figure 2C and 2D the DNAs were digested with Notl and EcoRI; these should give a different pattern depending upon the relative position of sites accessible to these enzymes in the plant DNA.
  • the blots were first hybridized with the thaumatin coding-sequence probe (Fig. 2A and 2C) . After the membranes were washed extensively at 65°C in 0.015 M NaCl/0.00015 M sodium citrate/0.1% SDS solution, they were exposed for twenty-four hours at -80°C with an intensifying screen. The membranes were heated (100°C in the aforementioned buffer for fifteen minutes) , and thereafter exposed for three days with an intensifying screen, to ensure that all probe was removed.
  • Figs. 2B and 2D The membranes were then rehybridized (Figs. 2B and 2D) with a probe derived from a low-pi ⁇ -amylase cDNA corresponding to "clone E" described by Rogers and Milliman, J. Biol. Chem. 258: 8169-74 (1983).
  • This cDNA is approximately 93% identical to the low-pi ⁇ -amylase genomic clone containing the amy32b promoter, and the sequence similarity is highly conserved in the 3' untranslated region.
  • the DNAs used on the blots were from: [1] plant "G12,” which was a 117-series transformant and the parent plant (p) of four progeny plants that germinated from G12 seed (of ten planted) ; [2] two plants, designated “10D1" and "12H2,” from the 083-series transformants; and [3] from a plant (C) that was grown alongside the others, but was not transformed.
  • DNA from the control plants did not hybridize to the thaumatin probe, although the expected hybridization of endogenous amylase genes with the "clone E" probe was observed, demonstrating that adequate amounts of DNA were indeed present on the filter.
  • the G12 parent and two progeny plants Nos.
  • plants 10D1 and 12H2 all yielded DNA with fragments that hybridized both to the thaumatin and the clone E probes.
  • plants 10D1 and 12H2 all yielded DNA with fragments that hybridized both to the thaumatin and the clone E probes.
  • Seeds were tested from two 083-series transformants, 10D1 and 12H2, and from an F 2 generation plant ("G12-2") from the 117-series plant G12. For each plant, eighty- five aleurone layers, plus layers from a nontransformed control, were labeled for twenty-four hours with [ 35 S]methionine, and aleurone proteins which were antigenically related to thaumatin were selected from the culture media on individual antithaumatin-sepharose affinity columns. These proteins were analyzed sequentially in two different electrophoretic systems. First, the proteins were loaded onto an acid-urea gel in the order: 5 ⁇ g thaumatin marker (T) , control proteins, T, 10D1, T, G12- 2, T, 12H2, T, T.
  • T 5 ⁇ g thaumatin marker
  • the gel was cut vertically between the right-most two T marker lanes.
  • the single T marker lane was electroblotted onto polyvinyldifluoride (PVDF) membrane (Immobilon ® ; product of Millipore Corp.) and stained with Coomassie Blue to identify the position of that protein.
  • PVDF polyvinyldifluoride
  • the appearance of that marker lane is presented in Figure 3, left portion, where the orientation corresponding to the direction of electrophoresis is top (+) to bottom (-) .
  • the thaumatin marker (Sigma Chemical Co.) always contained three different species of proteins, with the major component electrophoresing ahead of two minor species.
  • the remaining portion of the gel was cut into two portions, indicated by (a) and (b) , where (a) included 1 cm containing the trailing portion of the main marker band and the two minor components; (b) included 1 cm containing the main marker band and the portion of the gel immediately in front of it.
  • Each of these strips was then individually equilibrated with the proper buffer and placed into a long horizontal well of a standard sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) , and the proteins within the strip were electrophoresed, in the (- ) to (+) direction, to separate them according to molecular mass.
  • SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel
  • FIG. 3(a) and 3(b) is a representation of the stained membrane (top) and its autoradiograph (below) .
  • the positions of the marker proteins are indicated for the autoradiographs; these positions were confirmed by cutting out the appropriate bands from the membranes and re-exposing to x-ray film (not presented) .
  • (a) it can be seen that the two minor thaumatin marker bands migrating more anodally in the acetic acid- urea gel are indistinguishable in size to the bulk of thaumatin (22 kd) on SDS-PAGE, since the only stained protein band in those lanes (indicated by "t" above each) migrates with that marker.
  • This result indicates that the bands represented species of thaumatin with different overall charges but with substantially similar molecular masses, a result to be expected in light of the previously mentioned fact that "thaumatin” is a mixture of slightly different forms.
  • the autoradiograph demonstrates that the 12H2 sample contained a labeled protein that electrophoresed in the same manner as did the thaumatin markers (arrow) .
  • This protein (approx. 22 kd) was not present in control (C) , 10D1, or G12-2 samples.
  • the aleurone layers were washed with distilled water and then homogenized with a tissue homogenizer in 20 ml of TBS solution (0.15 M NaCl/0.05 M Tris-HCl; pH 7.9) containing 1 mM phenylmethylsulfonyl fluoride, 100 ⁇ M leupeptin and 2% insoluble polyvinylpyrrolidone.
  • the samples were diluted to 50 ml with TBS and made 0.1% with respect to NP40. Insoluble debris was removed by centrifugation in a desk centrifuge for ten minutes, and to each supernate was added 0.25 ml of 20% NP40, a detergent product sold by Shell Oil Co. The supernates were each incubated overnight, at 4 ⁇ C on a rotating shaker, with 1.5 ml of antithaumatin-sepharose, 1 ml of which contains about 9 mg of rabbit immunoglobulin selected by adsorption to a thaumatin-sepharose affinity column.
  • proteins specifically adherent to the column were eluted with 0.2 M glycine - HC1 (pH 2.2) and then precipitated with 10% trichloroacetic acid. Proteins were similarly selected from the media samples.
  • the precipitated protein samples were dissolved in sample buffer and loaded onto an acetic acid-urea gel in two sets: in one set, 20% of each sample was loaded sequentially, followed by two consecutive wells containing 5 ⁇ g each of thaumatin marker; the second set, separated by empty wells on either side from thaumatin markers was made up of the remaining 80% of each sample. After electrophoresis, the gel was cut vertically between the two center thaumatin marker lanes. The portion of the gel containing the first set of samples was electroblotted onto PVDF membrane and stained to visualize the transferred proteins.
  • FIG. 4A A representation of this blot, with its autoradiograph, is presented in Figure 4A.
  • the remaining half of the gel was cut horizontally into two strips: strip 'd' was 0.5 cm wide and included the trailing portion of the thaumatin marker; strip 'c' included the 0.5 cm of gel immediately to the anodal side of strip 'd'.
  • strip 'd' was 0.5 cm wide and included the trailing portion of the thaumatin marker
  • strip 'c' included the 0.5 cm of gel immediately to the anodal side of strip 'd'.
  • These two strips of gel included two prominent stained protein bands in the 12H2 extract sample lane that are not visualized in the other sample lanes.
  • Strip 'c' was cut to include only the four lanes containing the barley proteins.
  • Strip 'd' included the portions of the gel with thaumatin marker protein bracketing the four lanes with barley proteins.
  • On either side of the long well containing the gel strips were single wells loaded with thaumatin marker protein (left) , and a protein marker mixture (right) .
  • GUS coding sequence For the JR133 construct (Fig. 5C) , the GUS coding sequence was fused to the N-terminal coding sequence of the barley ⁇ -amylase gene, Amy6-4. The completed construct brackets the fused coding sequence between the Amy6-4 upstream/promoter region and the Amy6-4 3' sequences for RNA processing/poly(A) addition.
  • An example of the use of GUS in the Agrobacterium-mediated transformation of dicot plants has been described in Jefferson et al., EMBO J. 13: 3901-3907 (1987) .
  • Seeds were prepared for screening essentially as described in EXAMPLE 2. Grain to be screened was cut with a razor blade to remove ca. 1/5 of the grain end opposite the plant embryo. The seed end was then placed in a well of a 96-well microtiter dish. The remaining portion of each seed containing the embryo was placed in an identical position in a duplicate dish for later use. When initiating screening, grain ends were first sterilized by washing in 70% EtOH for 1 minute, then in 0.2% AgN0 3 for 20 minutes, by adding the solutions to microtiter dish wells and aspirating as appropriate. The seed ends were subsequently allowed to completely dry in a sterile tissue culture hood to ensure that fungal spores are killed.
  • incubation buffer (20 mM sodium succinate (pH 5.2), 10 mM CaCl 2 containing 10 "6 M GA 3 , 50 ⁇ g/ml carbenicillin, and 120 ⁇ g/ml amphotericin B (Fungizone ® ) ) was added. Incubation of the sterile seed ends and a row of ends (12) from control seeds continued for two days at room temperature in a humidified chamber.
  • homogenization buffer 50 mM NaP0 4 (pH 8), 10 mM EDTA, 0.1% NP40, 0.1% sarkosyl, and 1 mM phenyl methyl sulfonyl fluoride (PMSF) containing 1 mM MUG.
  • PMSF phenyl methyl sulfonyl fluoride
  • Figure 6 depicts the media (Fig. 6A) and extracts (Fig. 6B) from screening plate #2 of seeds from tillers injected with JR124.
  • the results demonstrate that well D2 fluoresces the brightest in both media and extracts, while well E4 may also give a positive result.
  • the variable amounts of starchy material carried over during the transfer process from the enzyme incubation plate to the plate for alkanization and viewing can account for the light-appearing wells in the plate with extracts (Fig. 6B) .
  • These light-appearing wells are easily distinguished from the blue fluorescence in wells D2 and E4 (identified in subsequent figures as 124-2D2 and 2E4, respectively) .
  • Seeds from tillers injected with construct JR129 were screened at the same time. Fluorescence for the positive seed 129-6B3 in media and extract samples was similarly identified, but was less intense than that of the 124 positives (124-2D2 and 2E4) .
  • Figure 7 presents results from assaying barley seed ends from tillers injected with construct JR133 for tissue extracts only (the media from the seed end incubations was not screened) .
  • Wells G6, G7, G8, and G10 (referred to in subsequent figures as 133-2G6, 2G7, 2G8, and 2G10, respectively) exhibited strong fluorescence as seen in comparison with wells containing extracts from control seeds (El-7) and empty wells (F5-12) .
  • Figure 8A provides the results from hybridizing Southern blots of DNA from two JR124 construct transformants 124-2D2 and 124-2E4 (A) , with a probe derived from the coding sequence of GUS. DNA from the two transformed plants was digested with BamHI f with EcoRI. or with a combination of both enzymes. Electrophoresis, transfer to a nylon membrane, and hybridization were performed as described above. The results indicate that the GUS probe hybridized to a -6.5 kb EcoRI fragment in each DNA preparation.
  • the probe hybridized to a -2.1 kb fragment (arrow) in each transformed plant; this is what was expected from the original construct if it were intact in the barley chromosomal DNA.
  • two fragments in the 2D2 plant hybridize (-12 kb and -2.5 kb) , while for plant 2E4, only one ( ⁇ 6.5 kb) fragment was identified. This finding is consistent with different positions and/or different final arrangements of the inserted genes in the barley chromosome. DNA from control plants did not hybridize to the GUS probe in this manner.
  • Figure 8B shows the results from different digests of the JR133 construct hybridized with the same GUS coding sequence probe.
  • Figure 8B demonstrates that all the different DNAs that were digested with a combination of Hindlll and Xhol gave a hybridizing fragment to the GUS probe of -7.3 kb whereas the control DNA did not have this fragment.
  • An identically sized fragment was generated by Hindlll alone; whereas Xhol does not cut barley DNA prepared by this technique.
  • a (G+C)-RICH, ALEURONE-TRANSFORMING CONSTRUCT Figure 9 presents the autoradiograph of a Southern blot of control barley DNA (C) for the F 2 generation progeny of the thaumatin transformants 10D1 and 12H2.
  • C control barley DNA
  • the blot was hybridized with a thaumatin probe.
  • the results demonstrate that the 10D1 and 12H2 progeny have a 2.5 kb hybridizing band diagnostic of the thaumatin transformation marker which is lacking in the control, indicating that the thaumatin sequence is stably inherited. Further, tests have been done that clearly show stable inheritance for as far as the third in-bred generation (two generations each for 10D1 and 12H2, and three generations for the G12 plants described in EXAMPLE 2) .
  • Original DNA preparations were made from the "parent" GUS transformants, that is, from the primary transformants.
  • Parent DNAs were prepared when the plants had two tillers and when the smaller tiller was estimated to be about 2 grams. At this stage, the second tiller (smallest) was then removed and used for DNA preparation.
  • 12 seeds from each transformant 124-2D2 and 133-2G7, -2G8, -2G10, -5A7 were planted. These seeds were all derived from the first (largest) tiller that developed because they were the first to mature. Additionally, more DNA from the parents was subsequently prepared in anticipation of progeny- parent blot comparisons.
  • JR133 Transformants All DNA from plants that germinated were analyzed. Only one seed from 2G8 germinated, and the resultant plant was negative (data not presented) .
  • JR124-2D2 Pedigree Consistent with previous results, the parent DNA isolated from tissue developing later lacked hybridizing sequences (Fig. 11) . Progeny numbers 4, 6, and 7 had bands on a BamHI-EcoRI digest that hybridized to GUS; for progeny numbers 3 and 5, the strongest bands were the expected 2.1 kb size, while progeny 6 and 7 also had large hybridizing fragments. The intensity of the 2.1 kb bands was greater than would have been expected for single copy sequences.
  • Hybridizing DNA in Unstably Transformed Plants In order to confirm the stability results, the structure and methylation patterns of hybridizing DNA were analyzed in the 133-series parents that were GUS- positive and in the 124-2D2#6 DNA which appeared to have multiple copies. These methylation patterns were then compared to those occurring in F 2 and F 3 generation plants that were positive for the thaumatin marker. Additionally, the structures of the small hybridizing fragments identified in 2G7#3 and 5A7#8 were analyzed.
  • the methylation pattern of the 133-series GUS- positive parent DNA fragments in 2G6 was determined and then compared to an equal amount of control DNA spiked with -3 copies per haploid genome of JR133 plasmid DNA (Fig. 12) .
  • Restriction enzymes that have the same recognition site (so-called isoschizomers) , but that have different responses to methylation of residues in that site were used.
  • Hindlll produced a -7.3 kb band; the band remained the same size following digestion with Hindlll plus Mbol.
  • the Mbol isoschizomer, Sau3AI gave the expected 500 bp hybridizing fragment.
  • Figure 13B demonstrates that the GUS-hybridizing fragments are free from undigested chromosomal DNA, and that their size did not change when digested with either BamHI or EcoRI.
  • Transient expression was thus usefully effected by means of integrated DNA characterized by extensive adenine methylation, but heritably stable integration was accomplished when such methylation was minimized. This principle can be applied in selecting or designing other genes for stable expression according to the present invention.
  • Tillers from oat plants derived from seeds were injected with DNA as described for barley plants in Example 2.
  • oat tillers were injected with
  • FIG. 15 provides the results of the screen for seeds in plates 4 (only extract screen is shown) , 5 (only media screen is shown) and 6.
  • Figs. 15A and 15B demonstrate the results for the media screen and the extract screen, respectively. The results indicate that in both the media and extract, the seed in well 6A4 exhibited a strong positive fluorescent signal indicating the presence of the transforming DNA, while the other wells did not appear to produce a positive signal.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Les capacités synthétiques d'un tissu d'endosperme sont mises en valeur pour la production d'un polypeptide exogène, par transformation d'une céréale ou d'une autre plante monocotylédone au moyen d'une construction génétique comportant une séquence structurelle codant pour le polypeptide et, en amont de celle-ci par rapport à la direction de transcription, un segment contenant au moins un élément régulateur qui produit ou règle l'expression de la séquence structurelle dans le tissu d'endosperme. En aval de la séquence structurelle, la construction génétique comporte également un segment qui contient un signal de traitement terminal permettant de compléter le traitement de l'ARNm à l'état naissant.
EP89908935A 1988-07-29 1989-07-27 Production de polypeptides pour usage commercial au moyen d'un tissu d'endosperme transforme genetiquement Withdrawn EP0428572A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22580088A 1988-07-29 1988-07-29
US225800 1988-07-29

Publications (1)

Publication Number Publication Date
EP0428572A1 true EP0428572A1 (fr) 1991-05-29

Family

ID=22846295

Family Applications (1)

Application Number Title Priority Date Filing Date
EP89908935A Withdrawn EP0428572A1 (fr) 1988-07-29 1989-07-27 Production de polypeptides pour usage commercial au moyen d'un tissu d'endosperme transforme genetiquement

Country Status (3)

Country Link
EP (1) EP0428572A1 (fr)
JP (1) JPH04500153A (fr)
WO (1) WO1990001551A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234834A (en) * 1987-06-19 1993-08-10 The Regents Of The University Of California Constructs for expression of monellin in plant cells
NL8901932A (nl) * 1989-07-26 1991-02-18 Mogen Int Produktie van heterologe eiwitten in planten of plantecellen.
DE4004800C2 (de) * 1990-02-13 2000-12-21 Aventis Cropscience Gmbh Im Habitus und Ertrag veränderte transgene Pflanzen
WO1991013993A1 (fr) * 1990-03-05 1991-09-19 The Upjohn Company Expression de proteines par l'intermediaire de sequences regulatrices specifiques de semences
US7033627B2 (en) 1990-03-23 2006-04-25 Syngenta Mogen B.V. Production of enzymes in seeds and their use
US5593963A (en) * 1990-09-21 1997-01-14 Mogen International Expression of phytase in plants
KR100225087B1 (ko) * 1990-03-23 1999-10-15 한스 발터라벤 피타아제의 식물내 발현
US5543576A (en) * 1990-03-23 1996-08-06 Mogen International Production of enzymes in seeds and their use
IL97645A (en) * 1990-03-23 1997-03-18 Gist Brocades Nv Production of enzymes in seeds and their use
IE913215A1 (en) * 1990-09-13 1992-02-25 Gist Brocades Nv Transgenic plants having a modified carbohydrate content
US5705375A (en) * 1990-09-13 1998-01-06 Mogen International, N.V. Transgenic plants having a modified carbohydrate content
US5723747A (en) * 1991-02-22 1998-03-03 Calgene, Inc. Wax esters in transformed plants
AU655277B2 (en) * 1991-05-24 1994-12-15 Universidad Politecnica De Madrid Novel antipathogenic peptides and compositions containing same
US5446127A (en) * 1991-05-24 1995-08-29 Universidad Politecnica De Madrid Antipathogenic peptides and compositions containing the same
GB9319429D0 (en) * 1993-09-21 1993-11-03 London Health Ass Methods and products for controlling immune responses in mammals
US5693506A (en) * 1993-11-16 1997-12-02 The Regents Of The University Of California Process for protein production in plants
GB9324707D0 (en) * 1993-12-02 1994-01-19 Olsen Odd Arne Promoter
US5824870A (en) * 1995-11-06 1998-10-20 Baszczynski; Chris Commercial production of aprotinin in plants
US5767379A (en) * 1995-11-06 1998-06-16 John Howard Commercial production of avidin in plants
GB9603069D0 (en) * 1996-02-14 1996-04-10 Medical Res Council Improvements in or relating to gene expression
US6255558B1 (en) 1996-02-14 2001-07-03 Btg International Limited Gene expression
JP2001501451A (ja) * 1996-03-05 2001-02-06 フリードリヒ ワイスハイメル マイツファブリク モルティング・プロセスによる、形質転換植物素材中に存在する貯蔵物質からの分解物質及び／又は転換物質の生成方法
GB9611981D0 (en) * 1996-06-07 1996-08-07 Zeneca Ltd Enhancement of gene expression
US6127145A (en) * 1997-02-13 2000-10-03 Applied Phytologics, Inc. Production of α1 -antitrypsin in plants
US6066781A (en) * 1997-02-13 2000-05-23 Applied Phytologics, Inc. Production of mature proteins in plants
WO1998036085A1 (fr) * 1997-02-13 1998-08-20 Applied Phytologics, Inc. Production de proteines matures dans des plantes
ES2276475T5 (es) 1997-09-30 2014-07-11 The Regents Of The University Of California Producción de proteínas en semillas de plantas
GB9724307D0 (en) * 1997-11-17 1998-01-14 Zeneca Ltd Improvements relating to protein accumulation
DE10015458A1 (de) * 2000-03-29 2001-10-11 Inst Pflanzengenetik & Kultur Verfahren zur raschen Herstellung von transgenen, markergen-freien Pflanzen
GB0207414D0 (en) * 2002-03-28 2002-05-08 Plant Bioscience Ltd Methods and means
DE102005035888A1 (de) * 2005-07-30 2007-02-01 Maltagen Forschung Gmbh Thaumatin aus transgenen monokotylen Pflanzen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983001176A1 (fr) * 1981-10-01 1983-04-14 Int Plant Research Inst Procede de modification genetique de cereales avec des vecteurs de transformation
US4956282A (en) * 1985-07-29 1990-09-11 Calgene, Inc. Mammalian peptide expression in plant cells
JPS63123325A (ja) * 1986-08-14 1988-05-27 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エ−・ファウ トランスジェニック単子葉植物、その種子および植物の調製方法
IL84459A (en) * 1986-12-05 1993-07-08 Agracetus Apparatus and method for the injection of carrier particles carrying genetic material into living cells
NL8701450A (nl) * 1987-06-22 1989-01-16 Solvay Werkwijze voor het transformeren van cellen.
EP0319353B1 (fr) * 1987-10-20 1996-10-02 Plant Genetic Systems N.V. Procédé pour la production de peptide biologiquement actif par l'expression de gènes de protéines de réserves modifiées dans les plantes transgèniques

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9001551A1 *

Also Published As

Publication number Publication date
AU4037289A (en) 1990-03-05
JPH04500153A (ja) 1992-01-16
AU638409B2 (en) 1993-07-01
WO1990001551A1 (fr) 1990-02-22

Similar Documents

Publication Publication Date Title
CA1341467C (fr) Production de polypeptides d'interet commercial a l'aide d'endosperme genetiquement modifie
EP0428572A1 (fr) Production de polypeptides pour usage commercial au moyen d'un tissu d'endosperme transforme genetiquement
JP4424756B2 (ja) 組織特異的プロモーターを用いたトランスジェニック植物およびその作出方法
Hansen et al. “Agrolistic” transformation of plant cells: integration of T-strands generated in planta
US7268272B2 (en) Genetic control of plant growth and development
EP0354687B1 (fr) Expression poussée du phytochrome dans des plantes transgéniques
US6172279B1 (en) Plant gene construct encoding a protein capable of disrupting the biogenesis of viable pollen
US8586355B2 (en) Embryo sac-specific genes
Maughan et al. Biolistic transformation, expression, and inheritance of bovine β-casein in soybean (Glycine max)
JPH0662870A (ja) 大豆ホスホエノールピルビン酸カルボキシラーゼ遺伝子のプロモーター領域及び５’非翻訳領域
CN1302328A (zh) 成花基因座t(ft)和经遗传修饰可调节开花的植物
Chourey et al. Tissue-specific expression and anaerobically induced posttranscriptional modulation of sucrose synthase genes in Sorghum bicolor M.
KR19990022728A (ko) 아비딘의 고농도 발현에 의한 식물에서의 웅성생식불능의 유도
US6472211B1 (en) Method of increasing transcription with nucleic acids encoding PABF
WO1993008682A1 (fr) Procedes d'obtention de graines de mais a haute teneur en methionine, et leurs utilisations
US6501007B1 (en) Method of dwarfing plants
AU638409C (en) Producing commercially valuable polypeptides with genetically transformed endosperm tissue
US6177614B1 (en) Control of floral induction in plants and uses therefor
US20030024013A1 (en) Gene controlling fruit size and cell division in plants
US6248936B1 (en) Sugarbeet storage-root-tissue-specific regulon
US20050086716A1 (en) Nucleic acids coding for a ISUM2A polypeptide and use of said nucleic acids to obtain transformed plants producing seeds altered in germ development
CA2379857A1 (fr) Nouveaux elements miniatures de type elements transposables de sequences repetees inverses (mite) et elements d'activation transcriptionnels
AU6174898A (en) Control of floral induction in plants and uses therefor
WO2002067663A1 (fr) Procedes de transfert medie par l'arnm d'informations genetiques dans des plantes, et produits resultants
AU8150801A (en) Control of floral induction in plants and uses therefor

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19910125

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19930604

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010327